Literature DB >> 12440818

Prevalence of genital human papillomavirus among Lebanese women.

A M Mroueh1, M A F Seoud, H G Kaspar, P A Zalloua.   

Abstract

PURPOSE: The purpose of this study was to determine the prevalence of human papillomavirus (HPV), and more specifically of HPV 16, in a group of Lebanese women.
MATERIALS AND METHODS: Type-specific prevalence of cervical HPV and the presence of cytological abnormalities were determined in a cohort of Lebanese women. The population included 1,026 women, 18-76 years, seeking routine gynecological care at a tertiary care center. Demographic and behavioral data were collected. HPV DNA was detected in cervical scrapes by polymerase chain reaction using consensus primers. Cervical cytological abnormalities were identified by Papanicoleau (Pap) smears.
RESULTS: The mean age of our population was 40 +/- 11.3 years. General HPV DNA was detected in 50 patients (4.9%). The high-risk HPV type 16 DNA was detected in 31 patients (3%). Patients with HPV 16 were more likely to have an abnormal pap smear than those with negative tests (6.6% vs 1.6%, p < 0.05), and more likely, but not significantly, to be smokers (21.4% vs 18.4%, p = 0.5). The age-specific prevalence of HPV increased with age and peaked at 60-69 years.
CONCLUSIONS: The prevalence of HPV in this small group of Lebanese women is similar to its prevalence in the Mediterranean countries. The presence of HPV, its known association with the development of cervical neoplasia, and the lack of a universal screening program for cervical cancer in our country should be used to enforce implementation of proper screening programs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12440818

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  6 in total

1.  Low rate of human papillomavirus vaccination among schoolgirls in Lebanon: barriers to vaccination with a focus on mothers' knowledge about available vaccines.

Authors:  Maria J Abou El-Ola; Mariam A Rajab; Dania I Abdallah; Ismail A Fawaz; Lyn S Awad; Hani M Tamim; Ahmad O Ibrahim; Anas M Mugharbil; Rima A Moghnieh
Journal:  Ther Clin Risk Manag       Date:  2018-03-27       Impact factor: 2.423

2.  Human papilloma virus-16/18 cervical infection among women attending a family medical clinic in Riyadh.

Authors:  Tarfah Al-Muammar; Mohammed N Al-Ahdal; Ahmed Hassan; George Kessie; Damian M Dela Cruz; Gamal E Mohamed
Journal:  Ann Saudi Med       Date:  2007 Jan-Feb       Impact factor: 1.526

3.  Cervix Uteri Cancer in Lebanon: Incidence, Temporal Trends, and Comparison to Countries From Different Regions in the World.

Authors:  Najla A Lakkis; Mona H Osman; Reem M Abdallah
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 3.302

4.  High-risk human papillomaviruses and Epstein-Barr virus in breast cancer in Lebanese women and their association with tumor grade: a molecular and tissue microarray study.

Authors:  Karim Nagi; Ishita Gupta; Nawaf Jurdi; Ayesha Jabeen; Amber Yasmeen; Gerald Batist; Semir Vranic; Ala-Eddin Al-Moustafa
Journal:  Cancer Cell Int       Date:  2021-06-10       Impact factor: 5.722

5.  Prevalence of cervical neoplastic lesions and Human Papilloma Virus infection in Egypt: National Cervical Cancer Screening Project.

Authors:  Howayda S Abd el-All; Amany Refaat; Khadiga Dandash
Journal:  Infect Agent Cancer       Date:  2007-07-04       Impact factor: 2.965

6.  Prevalence of high-risk human papillomavirus infections in healthy Saudi women attending gynecologic clinics in the western region of Saudi Arabia.

Authors:  Nabeel Salem Bondagji; Faten Salah Gazzaz; Khalid Sait; Layla Abdullah
Journal:  Ann Saudi Med       Date:  2013 Jan-Feb       Impact factor: 1.526

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.